Browse > Article

Implication of embB Gene Mutation in Ethambutol-Susceptible Clinical Isolates of Mycobacterium tuberculosis  

Park, Young Kil (Korean Institute of Tuberculosis)
Shin, Sonya (Brigham and Women's Hospital)
Kim, Sang Jae (International Union Against Tuberculosis and Lung Disease)
Koh, Won-Jung (Sungkyunkwan University of Medicine)
Kwon, O Jung (Sungkyunkwan University of Medicine)
Kim, Bum Jun (Seoul National University College of Medicine)
Kook, Yoon Ho (Seoul National University College of Medicine)
Cho, Sang Nae (Yonsei University College of Medicine)
Lew, Woo Jin (Korean Institute of Tuberculosis)
Bai, Gill Han (Korean Institute of Tuberculosis)
Publication Information
Tuberculosis and Respiratory Diseases / v.59, no.3, 2005 , pp. 266-271 More about this Journal
Abstract
Background : Ethambutol(EMB) is one of the first-line drugs included in short-course anti-tuberculosis therapy. The point mutations in embB gene have been speculated to be associated EMB resistance. However, detection of embB mutations at these positions have been observed in both EMB-susceptible isolates; thus, it remains controversial whether these mutations are associated with EMB resistance Methods : The 36 M. tuberculosis isolates were selected from clinical isolates which tested susceptible to EMB and resistant to at least one drug. DNA extracted from the isolates was analyzed by amplifying embB gene. The PCR products were purified and directly sequenced. We reviewed the history of past drug susceptibility test results. Results : Out of 36 EMB-susceptible strains, 3 strains (8.3%) had a mutation in codon 306 or 406 of the embB gene. These three strains had at least isoniazid resistance. They grew at 1.0 mcg/ml of EMB in Lowenstein-Jensen media. The patients of the strains were continuously smear-positive for over 3 years despite taking TB therapy. One strain had been EMB-resistant in past drug susceptibility tests. Conclusion : EMB-susceptible strains containing embB mutation may be caused by decreased viability in vitro test not by itself.
Keywords
embB gene; Mutation; Ethambutol; Mycobacterium tuberculosis; Drug resistance; Korea;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles B, et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 1997;3:567-70   DOI   ScienceOn
2 van Rie A, Warren R, Mshanga I, Jordaan AM, van der Spuy GD, Richardson M, et al. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a highincidence community. J Clin Microbiol 2001;39:636- 41   DOI   ScienceOn
3 van Doorn HR, Kuijper J, van der Ende A, Welten AG, van Soolingen D, de Haas DE, et al. The susceptibility of Mycobacterium tuberculosis to isoniazid and the $Arg{\to}Leu$ mutation at codon 463 of katG are not associated. J Clin Microbiol 2001;39:1591-4   DOI   ScienceOn
4 Karlson AG. The in vitro activity of ethambutol (dextro-2,2'-〔ethlenediimino〕- di-1-butanol) against tubercle bacilli and other microorganisms. Am Rev Respir Dis 1961;4:905-6
5 Sreevatsan S, Stockbauer KE, Pan X, Kreiswirth BN, Moghazeh SL, Jacobs WR Jr, et al. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 1997;41:1677-81
6 Lee AS, Othman SN, Ho YM, Wong SY. Novel mutation within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2004;48:4447-9   DOI   ScienceOn
7 Park YK, Yu HK, Park CH, Ryu SW, Lee SH, Shim MS, et al. Detection of embB gene mutation of Mycobacterium tuberculosis by reverse hybridization. Tuberc Respir Dis 2005;58:129-34
8 van Embden JD, Cave MD, Crawford JT, Dale JW, Esienach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9
9 Takayama K, Kilburn JO. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemorther 1989;33: 1493-9   ScienceOn
10 Alcaide F, Pfyffer GE, Telenti A. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother 1997;41: 2270-3
11 Mokrousov I, Oten T, Vyshnevskiy B, Narvskaya O. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from northwestern Russia: implications for genotypic resistance testing. J Clin Microbiol 2002;40:3810-3   DOI   ScienceOn
12 Ramaswamy SV, Amin AG, Goksel S, Stager CE, Dou SJ, Sahly HE, et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuꠀ berculosis. Antimicrob Agents Chemother 2000;44:326- 36   DOI   ScienceOn
13 Kim SJ, Bai GH, Hong YP. Drug resistant tuberculosis in Korea, 1994. Int J Tuberc Lung Dis 1997;1:302-8